ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

Provision of HTLV Pathology Services

Imperial College Healthcare NHS Trust · award, contract

Tender information last checkedLast checked 14 Oct 2026, 10:36.

Opportunity overview

The HTLV pathology service will support the diagnosis, prognosis and<br/>monitoring of:<br/><br/>• HTLV infection with the provision of assays to detect, type and<br/>quantify HTLV infection, and<br/>• HTLV associated diseases particularly detection of high risk for or<br/>early disease and the monitoring of interventions to inform disease<br/>management.

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Classification

  • CPV85111800 — Pathology services

Lots

  • The HTLV pathology service will support the diagnosis, prognosis and<br/>monitoring of:<br/><br/>• HTLV infection with the provision of assays to detect, type and<br/>quantify HTLV infection, and<br/>• HTLV associated diseases particularly detection of high risk for or<br/>early disease and the monitoring of interventions to inform disease<br/>management.<br/>An award has been made under PSR direct award process A.<br/>Total contract value of £376,268.00 between 05/10/26-04/10/28.Value not stated

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
C474616
Status
complete
Main Procurement Category
services
Procurement Method
limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Why this procedure was chosen
The Molecular Diagnostic Unit (MDU) at Imperial College London <br/>is the only capable provider. <br/>The MDU provides NCHR with bespoke diagnostic assays that <br/>have been developed and validated for NCHR by the Section of <br/>Virology for patient benefit. These assays are essential for the <br/>assessment of HTLV-1-associated disease risk and are used to <br/>determine the frequency of clinic visits, (optimizing the use of <br/>clinical services), detect and allow early treatment of HTLV-1<br/>associated disease and monitor treatment responses. <br/>Continued provision of these assays by the MDU is justified on <br/>the following grounds: <br/>• The assays were developed by the MDU as part of the <br/>HTLV National Service provision. <br/>• The assays are either only available in the UK at the <br/>MDU (HTLV proviral quantification) or are only available <br/>in the World at the MDU (HTLV Clonality Assay). <br/>• The assays would not have been developed without the <br/>partnership between ICHNT/ICL. <br/>• Samples sent for proviral load quantification are stored <br/>viably to allow access to cells for the HTLV clonality <br/>Assay later (once the proviral load is known). <br/>• The MDU is uniquely placed to provide interpretation and <br/>clinical support. <br/>• All patients in England receive the same standard of care, which <br/>is world leading. The Direct Award Process A justification is <br/>based on the provider’s specialist HTLV assay capability, <br/>validated methodology, continuity of stored viable samples, <br/>UKAS-accredited laboratory provision, and clinical integration <br/>with the National Centre for Human Retrovirology. (Supporting <br/>evidence available and retained to demonstrate that there is no <br/>realistic alternative provider for the full requirement)

Legal basis

Id
32014L0024
Scheme
CELEX

Classification

Scheme
CPV
Id
85111800
Description
Pathology services

Procedure reasons

Entry 1
Scheme
TED_PT_AWARD_CONTRACT_WITHOUT_CALL
Id
D_OUTSIDE_SCOPE
Description
The procurement falls outside the scope of application of the directive

Lots and requirements

Entry 1
Id
1
Description
The HTLV pathology service will support the diagnosis, prognosis and<br/>monitoring of:<br/><br/>• HTLV infection with the provision of assays to detect, type and<br/>quantify HTLV infection, and<br/>• HTLV associated diseases particularly detection of high risk for or<br/>early disease and the monitoring of interventions to inform disease<br/>management.<br/>An award has been made under PSR direct award process A.<br/>Total contract value of £376,268.00 between 05/10/26-04/10/28.
Has Options
No
Status
cancelled

Award criteria

Criteria

Criterion 1
Name
No alternative supplier
Type
quality
Description
100
Criterion 2
Type
price
Description
0

Items and delivery

Item 1
Id
1
Related Lot
1

Additional Classifications

Entry 1
Scheme
CPV
Id
85111800
Description
Pathology services

Delivery locations

Entry 1
Region
UKI

Buyer, suppliers and contacts

Organisation 1
Name
Imperial College Healthcare NHS Trust
Id
GB-FTS-141135

Identifier

Legal Name
Imperial College Healthcare NHS Trust

Address

Street Address
St Mary's Hospital, Praed Street
Locality
London
Region
UKI33
Postal Code
W2 1NY
Country Name
United Kingdom

Contact

Roles

buyer

Details

Classifications

Entry 1
Scheme
TED_CA_TYPE
Description
NHS
Entry 2
Scheme
COFOG
Id
07
Description
Health
Organisation 2
Name
Molecular Diagnostic Unit, Imperial College London
Id
GB-FTS-187546

Identifier

Legal Name
Molecular Diagnostic Unit, Imperial College London

Address

Street Address
Faculty of Medicine Room I.2.03 2nd Floor Lift Bank D Chelsea & Westminster Hospital 369 Fulham Road London
Locality
London
Region
UKI
Postal Code
SW10 9NH
Country Name
United Kingdom

Contact

Roles

supplier

Details

Scale
sme
Organisation 3
Name
NHS England
Id
GB-FTS-130973

Identifier

Legal Name
NHS England

Address

Street Address
Wellington House, 133-135 Waterloo Rd
Locality
London
Postal Code
SE1 8UG
Country Name
United Kingdom

Contact

Roles

reviewBody

Details

Award information

Award 1
Id
096784-2026-1
Status
active

Related lots

1

Suppliers

Supplier 1
Id
GB-FTS-187546
Name
Molecular Diagnostic Unit, Imperial College London

Contracts and changes

Entry 1
Id
096784-2026-1
Award ID
096784-2026-1
Status
active
Date Signed
24 Sept 2026, 00:00

Value

Amount
376,268
Currency
GBP

Recorded locations

  • Buyer location · London · UKI33 · W2 1NY · United Kingdom
  • Delivery location · UKI

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. 096784-2026award, contract ·

PROCURAAXIS AWARD ANALYSIS

Award outcome intelligence

Evidence-bound analysis of the published award appears below the official tender and award information.

ANALYSIS PREVIEW

Award intelligence at a glance

Imperial College Healthcare NHS Trust published an award and contract notice for HTLV pathology services. The notice identifies Molecular Diagnostic Unit, Imperial College London as the sole awarded supplier and records a GBP 376,268 contract signed on 24 September 2026. The published lot is also marked cancelled, creating an unresolved status contradiction.

Published outcome signals

  • Notice statusAward and contract notice published; source process status completeEvidence: Process display status is 'awarded', source status is 'complete', and release tags are award and contract.
  • Award statusActiveEvidence: Award 096784-2026-1 has status 'active'.
  • Contract statusActive; signed 24 September 2026Evidence: Contract 096784-2026-1 has status 'active' and dateSigned 2026-09-24.
87% approved-analysis confidence1 supplier record analysed4 source limitations

SOURCE AND FRESHNESS

Traceable procurement data

Source
Find a Tender
Notice reference
096784-2026
OCID
ocds-h6vhtk-07870c
First published
14 Oct 2026
Last checked
14 Oct 2026, 10:36
Notice versions reviewed
1
View Find a Tender notice ↗

HOW THIS WAS PREPARED

Approved, evidence-bound analysis

ProcuraAxis structures information found in published procurement records, checks the result for consistency and publishes only approved analysis. Confidence describes the completeness and consistency of the available source information; it is not a guarantee of eligibility or contract award.

Analysis status
Approved for publication
Analysed
14 Oct 2026
Read the analysis methodology →